Indefinite Delivery Contract HHSF223201610028I

This federal Indefinite Delivery Contract (IDC) was awarded by the U.S. Food and Drug Administration (FDA), a civilian agency, to Integrated Behavioral Health, Inc., a for-profit subchapter S corporation. The $10 million IDC provides data licensing, data acquisition and management, and drug use surveillance services to support the FDA's post-marketing surveillance of non-medical use of pharmaceuticals and use of illicit drug substances. Two task orders have been issued under this IDC. The...

This Indefinite Delivery Contract (IDC) was awarded by the Food and Drug Administration (FDA) to Iqvia Government Solutions Inc., a prominent for-profit organization specializing in healthcare data, analytics, and clinical research services. The contract has a ceiling value of $16,803,000.00 and a period of performance from August 20, 2025, to August 21, 2027. The purpose of this IDC is to provide the FDA's Center for Drug Evaluation and Research with comprehensive access to outpatient...

This Indefinite Delivery Contract (IDC) was awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services (HHS), to Iqvia Government Solutions Inc., a for-profit provider of advanced analytics, technology solutions, and clinical research services. The contract, valued at up to $2,397,717.80, is for ACCESS TO HOSPITAL INPATIENT AND EMERGENCY DEPARTMENT DRUG UTILIZATION DATA. This single-award IDC, which does not include any set-asides,...

This Indefinite Delivery Contract (IDC) was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Technical Resources International, Inc. (TRI), a minority-owned, woman-owned, and Hispanic American-owned small business based in Bethesda, Maryland. The contract, valued at a ceiling of $2,500,000, is for the Pharmacokinetic Analysis Resource Center, which will provide support to clinical pharmacology and...

The Department of Health and Human Services' Food and Drug Administration (FDA) awarded an Indefinite Delivery Contract (IDC) valued at $45 million to Iqvia Government Solutions Inc., a leading provider of healthcare data, analytics, and related services to federal agencies. The contract enables the FDA to issue task orders for access to outpatient prescription and patient-level drug utilization data to support its regulatory programs and post-market drug safety monitoring initiatives over a...

The National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health, awarded a single-award Indefinite Delivery Contract valued at $44.3 million to The Emmes Company, LLC on September 5, 2022, with a five-year performance period extending through September 4, 2027. This IDV contract (N01DA-22-2253) establishes a Data, Statistics, and Clinical Trial Support Center to provide comprehensive research support services to the National Drug Abuse Treatment Clinical...

The Food and Drug Administration (FDA) has awarded a $45 million single-award Indefinite Delivery Contract (IDC) to Source Healthcare Analytics LLC for the "ACCESS TO OUTPATIENT LONGITUDINAL DATA IDIQ" over a 5-year period ending in May 2025. The purpose of this contract is to procure real-world data to aid the FDA in monitoring drug safety and effectiveness. Under this IDC, the FDA has issued Task Order 1, valued at $13,119,440, to Source Healthcare Analytics LLC for the...

The Department of Health and Human Services Food and Drug Administration awarded a single award indefinite delivery contract to Iqvia Government Solutions Inc. to provide hospital drug utilization data and regulatory drug utilization services. The base period of performance is from March 2020 through March 2025 with a potential value of $9 million. Under the first delivery order valued at $3.667 million, Iqvia will deliver hospital drug data from Silver Spring, Maryland through April 2025. The...

The federal contract IDV award, valued up to $10 million, was issued by the U.S. Food and Drug Administration (FDA) to the Denver Health and Hospital Authority (Denver Health), a U.S. local/state government entity and healthcare provider. The contract provides data resources to support the FDA's post-marketing surveillance of nonmedical use of pharmaceuticals and illicit drug use. Under this IDV, Denver Health has been awarded multiple firm fixed-price delivery orders. These include a $205,010...

This indefinite delivery contract (IDC) was awarded by the Substance Abuse and Mental Health Services Administration (SAMHSA), a civilian agency within the U.S. Department of Health and Human Services, to Education Development Center, Inc. (EDC), a nonprofit organization. The contract, valued at up to $1,000, has a performance period through July 2027 and does not involve any set-asides. The purpose of this IDC is to provide SAMHSA with training, technical assistance, and resources to support...